Global /United Kingdom /Healthcare /Drug Manufacturers - Specialty & Generic /ABTI

Alterola Biotech, Inc.

ABTI

• OTCMKTS: ABTI • Delayed

0.0051USD 0%

As of 5 June 2026, Alterola Biotech, Inc. has a market cap of $7.55M USD, ranking #42714 globally and #966 in the United Kingdom. It ranks #3774 in the Healthcare sector, and #262 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

42714

Country Rank

966

Sector Rank

3774

Industry Rank

262

Key Stats

Market Cap

$7.55MUSD

Enterprise Value

$9.62MUSD

Net Income (TTM)

-$2.78MUSD

PB Ratio

-3.4

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

David Hitchcock open_in_new

Website

alterola-abti.com/ open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-	0%	2K%	-97%	0%	42%	-90%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	ABTI Alterola Biotech Inc ISIN: US02152V1035 Shares Out.: Shares Outstanding: 1.46B¹ Shares Float: 139.938M² TV: TradingView: OTC: ABTI SA: Stock Analysis: OTC: ABTI YF: Yahoo Finance: ABTI GF: Google Finance: OTCMKTS: ABTI BA: Barron's: ABTI MS: Morningstar: PINX: ABTI	0.0051 USD	TV: TradingView: OTC: ABTI SA: Stock Analysis: OTC: ABTI YF: Yahoo Finance: ABTI GF: Google Finance: OTCMKTS: ABTI BA: Barron's: ABTI MS: Morningstar: PINX: ABTI

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Alterola Biotech, Inc.

Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
Hikma Pharmaceuticals PLC LSE: HIK	$4.0B 2.98B GBP 53K%	10.3	United Kingdom
Allergy Therapeutics plc LSE: AGY	$875.11M 652.25M GBP 11K%	-	United Kingdom
Applied Nutrition Plc LSE: APN	$721.15M 537.5M GBP 9K%	19.5	United Kingdom
Animalcare Group plc LSE: ANCR	$308.48M 229.92M GBP 4K%	73.8	United Kingdom
ImmuPharma plc LSE: IMM	$35.16M 26.2M GBP 365%	-	United Kingdom
Provexis plc LSE: PXS	$32.26M 24.05M GBP 327%	-	United Kingdom

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.93B 108.92B ILS 502K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 391K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 210K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.11B 1.06T INR 147K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 145K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 120K%	80.6	China

chevron_leftBack